Yiquan Xue
Publications by Year
Research Areas
Immune Cell Function and Interaction, Cancer-related molecular mechanisms research, Immune cells in cancer, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research
Most-Cited Works
- → The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation(2014)1,150 cited
- → IFN-γ Primes Macrophage Activation by Increasing Phosphatase and Tensin Homolog via Downregulation of miR-3473b(2014)146 cited
- → CXCR2+ MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion(2017)100 cited
- → Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity(2017)81 cited
- → Interferon-inducible cytoplasmic lncLrrc55-AS promotes antiviral innate responses by strengthening IRF3 phosphorylation(2019)61 cited
- → CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond(2024)55 cited
- → Natural killer cells in cancer immunotherapy(2024)27 cited
- → Deficiency of tumor-expressed B7-H3 augments anti-tumor efficacy of anti-PD-L1 monotherapy rather than the combined chemoimmunotherapy in ovarian cancer(2022)8 cited
- → SCRN1 confers hepatocellular carcinoma resistance to ferroptosis by stabilizing GPX4 via STK38-mediated phosphorylation(2025)2 cited
- → Deficiency of Tumor-Expressed B7H3 Augments Anti-Tumor Efficacy of Paclitaxel or Anti-PDL1 Monotherapy Rather than Their Combined Chemoimmunotherapy in Ovarian Cancer(2022)